Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples
Adibi, Jennifer J.
Whyatt, Robin M.
Calafat, Antonia M.
Bhat, Hari K.
Perera, Frederica P.
Silva, Manori J.
MetadataShow full item record
CitationAdibi, Jennifer J., Robin M. Whyatt, Paige L. Williams, Antonia M. Calafat, David Camann, Robert Herrick, Heather Nelson, et al. 2008. Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples. Environmental Health Perspectives 116(4): 467-473.
AbstractBackground: Although urinary concentrations of phthalate metabolites are frequently used as biomarkers in epidemiologic studies, variability during pregnancy has not been characterized. Methods: We measured phthalate metabolite concentrations in spot urine samples collected from 246 pregnant Dominican and African-American women. Twenty-eight women had repeat urine samples collected over a 6-week period. We also analyzed 48-hr personal air samples (n = 96 women) and repeated indoor air samples (n = 32 homes) for five phthalate diesters. Mixed-effects models were fit to evaluate reproducibility via intraclass correlation coefficients (ICC). We evaluated the sensitivity and specificity of using a single specimen versus repeat samples to classify a woman’s exposure in the low or high category. Results: Phthalates were detected in 85–100% of air and urine samples. ICCs for the unadjusted urinary metabolite concentrations ranged from 0.30 for mono-ethyl phthalate to 0.66 for monobenzyl phthalate. For indoor air, ICCs ranged from 0.48 [di-2-ethylhexyl phthalate (DEHP)] to 0.83 [butylbenzyl phthalate (BBzP)]. Air levels of phthalate diesters correlated with their respective urinary metabolite concentrations for BBzP (r = 0.71), di-isobutyl phthalate (r = 0.44), and diethyl phthalate (DEP; r = 0.39). In women sampled late in pregnancy, specific gravity appeared to be more effective than creatinine in adjusting for urine dilution. Conclusions: Urinary concentrations of DEP and DEHP metabolites in pregnant women showed lower reproducibility than metabolites for di-n-butyl phthalate and BBzP. A single indoor air sample may be sufficient to characterize phthalate exposure in the home, whereas urinary phthalate biomarkers should be sampled longitudinally during pregnancy to minimize exposure misclassification.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:4889516